2075 related articles for article (PubMed ID: 28174608)
41. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer.
Yang CM; Wang TH; Chen HC; Li SC; Lee MC; Liou HH; Liu PF; Tseng YK; Shiue YL; Ger LP; Tsai KW
Clin Epigenetics; 2016; 8():129. PubMed ID: 27933111
[TBL] [Abstract][Full Text] [Related]
42. Expression and epigenetic regulation of DACT1 and DACT2 in oral squamous cell carcinoma.
Schussel JL; Kalinke LP; Sassi LM; de Oliveira BV; Pedruzzi PA; Olandoski M; Alvares LE; Garlet GP; Trevilatto PC
Cancer Biomark; 2015; 15(1):11-7. PubMed ID: 25524937
[TBL] [Abstract][Full Text] [Related]
43. Oral cancers preceded by proliferative verrucous leukoplakia exhibit distinctive molecular features.
Herreros-Pomares A; Hervás D; Bagan-Debon L; Proaño A; Garcia D; Sandoval J; Bagan J
Oral Dis; 2024 Apr; 30(3):1072-1083. PubMed ID: 36892444
[TBL] [Abstract][Full Text] [Related]
44. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT
Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764
[TBL] [Abstract][Full Text] [Related]
45. Identification of potential CpG sites for oral squamous cell carcinoma diagnosis via integrated analysis of DNA methylation and gene expression.
Chen L; Wang D
World J Surg Oncol; 2021 Jan; 19(1):16. PubMed ID: 33468155
[TBL] [Abstract][Full Text] [Related]
46. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
[TBL] [Abstract][Full Text] [Related]
47. Machine learning analysis of DNA methylation in a hypoxia-immune model of oral squamous cell carcinoma.
Zeng H; Luo M; Chen L; Ma X; Ma X
Int Immunopharmacol; 2020 Dec; 89(Pt B):107098. PubMed ID: 33091815
[TBL] [Abstract][Full Text] [Related]
48. Promoter-associated DNA methylation & expression profiling of genes (
Khongsti S; Shunyu BN; Ghosh S
Indian J Med Res; 2019 Dec; 150(6):584-591. PubMed ID: 32048621
[TBL] [Abstract][Full Text] [Related]
49. Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.
Lai YH; He RY; Chou JL; Chan MW; Li YF; Tai CK
J Transl Med; 2014 Sep; 12():237. PubMed ID: 25179542
[TBL] [Abstract][Full Text] [Related]
50. Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics.
Choudhury JH; Ghosh SK
PLoS One; 2015; 10(6):e0129808. PubMed ID: 26098903
[TBL] [Abstract][Full Text] [Related]
51. Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population.
Goel H; Mathur R; Syeda S; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2021 Mar; 22(3):977-982. PubMed ID: 33773564
[TBL] [Abstract][Full Text] [Related]
52. Aberrant promoter methylation of PTEN gene among Indian
patients with oral squamous cell carcinoma.
Alyasiri NS; Ali A; Kazim Z; Gupta S; Mandal AK; Singh I; Rizvi MA
Int J Biol Markers; 2013 Sep; 28(3):298-302. PubMed ID: 23787493
[TBL] [Abstract][Full Text] [Related]
53. Aberrant gene promoter methylation of E-cadherin, p16
Burassakarn A; Pientong C; Sunthamala N; Chuerduangphui J; Vatanasapt P; Patarapadungkit N; Kongyingyoes B; Ekalaksananan T
Med Oncol; 2017 Jul; 34(7):128. PubMed ID: 28573642
[TBL] [Abstract][Full Text] [Related]
54. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
[TBL] [Abstract][Full Text] [Related]
55.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
56. Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma.
Ye MH; Huang XY; Li CJ; Wu QJ; Liu F
Chin J Dent Res; 2023 Dec; 26(4):235-248. PubMed ID: 38126369
[TBL] [Abstract][Full Text] [Related]
57. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients.
Supić G; Kozomara R; Branković-Magić M; Jović N; Magić Z
Oral Oncol; 2009 Dec; 45(12):1051-7. PubMed ID: 19665921
[TBL] [Abstract][Full Text] [Related]
58. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.
Chakraborty S; Mohiyuddin SM; Gopinath KS; Kumar A
BMC Cancer; 2008 Jun; 8():163. PubMed ID: 18538015
[TBL] [Abstract][Full Text] [Related]
59. The epigenetic landscape of oral squamous cell carcinoma.
Jithesh PV; Risk JM; Schache AG; Dhanda J; Lane B; Liloglou T; Shaw RJ
Br J Cancer; 2013 Feb; 108(2):370-9. PubMed ID: 23287992
[TBL] [Abstract][Full Text] [Related]
60. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells.
Gasche JA; Hoffmann J; Boland CR; Goel A
Int J Cancer; 2011 Sep; 129(5):1053-63. PubMed ID: 21710491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
